Welcome to PLS-Design
Our Business is Modulation of the Immune System
Re-Inventing Immunotherapy - Building on Induction of Tolerance
We create novel immunotherapies for allergy and autoimmune diseases
Our Concept & Patent-protected Technologies
Basic Concept: Peripheral immune modulation - Systemic tolerance
Hydrogel & Liposomes
We are developing efficient systems for drug delivery
Focus on regulatory T-cells
We aim at utilizing natural tolerance pathways
Small molecule immune modulators
Immune cell attraction and modulation
Recombinant immune modulators
Specific and effective modulation
Recombinant allergens
Component-resolved diagnosis & efficient immunotherapy
Our Management
Leo W. Tristram
CEO / CFOMr. Tristram has over 25 years of experience in the bio-pharmaceutical industry. Key areas of responsibility have included Business Development and Strategic Planning, both in early-stage and larger company settings. He has very relevant experience in setting up and financing new companies. He holds an MBA from the Ludwig-Maximilians-Universität München as well as diplomas in Economics and Legal Affairs. Former positions include senior management positions at Texas Instruments Inc. and OTTO Versand GmbH & Co. Mr. Tristram is co-founder of PLS-Design GmbH and leads the company as CEO and CFO.
Contact Leo W. TristramProf. Dr. med. Reinhard Bredehorst
CSOProf. Bredehorst has over 20 years of experience in the bio-pharmaceutical industry. Key areas of responsibility have included the development of novel concepts for the treatment of allergic diseases and appropriate patent protection of such concepts. Prof. Bredehorst is co-founder of PLS-Design GmbH and since 2004 CSO of the company. Following academic positions at the University Hospital Hamburg Eppendorf and Georgetown University (Washington DC), since 1995 he is Professor of Biochemistry and Molecular Biology at the University of Hamburg. Prof. Bredehorst is board certified for Clinical Chemistry and Clinical Biochemistry.
Contact Reinhard Bredehorst